Comments
FDA staff question Pfizer arthritis drug benefits
08.05.2012. | WASHINGTON (Reuters) - U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections....
